Study: Spiriva Beats Serevent for COPD Flare-ups

Once-daily Spiriva (tiotropium) may be more effective at reducing risk for exacerbations among people with moderate to severe chronic obstructive pulmonary disease (COPD) than Serevent (salmeterol), a new study shows.

Go here to read the rest:

Study: Spiriva Beats Serevent for COPD Flare-ups

Posted by on March 23, 2011. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.